摘要翻译：
糖尿病被认为是一种与最新的冠状病毒疾病2019（新冠肺炎）有关的关键共病，该疾病通过严重急性呼吸系统综合征冠状病毒2（新型冠状病毒）传播。糖尿病患者感染新型冠状病毒的威胁较高。根据全球地区的不同，感染新冠肺炎疫情的患者中有20%至50%患有糖尿病。本文讨论了糖尿病患者的风险，以及在这种流行病情况下控制糖尿病的建议。文章还讨论了新冠肺炎在全球各地区的案例研究以及各国为控制病毒的影响而采取的预防措施。本文介绍了几种智能医疗解决方案，为糖尿病患者提供葡萄糖和胰岛素控制，以保护他们免受COVID-19的侵害。
---
英文标题：
《Smart Healthcare for Diabetes: A COVID-19 Perspective》
---
作者：
Amit M. Joshi and Urvashi P. Shukla and Saraju P. Mohanty
---
最新提交年份：
2020
---
分类信息：

一级分类：Quantitative Biology        数量生物学
二级分类：Other Quantitative Biology        其他定量生物学
分类描述：Work in quantitative biology that does not fit into the other q-bio classifications
不适合其他q-bio分类的定量生物学工作
--

---
英文摘要：
  Diabetes is considered as an critical comorbidity linked with the latest coronavirus disease 2019 (COVID-19) which spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). The diabetic patients have higher threat of infection from novel corona virus. Depending on the region in the globe, 20% to 50% of patients infected with COVID-19 pandemic had diabetes. The current article discussed the risk associated with diabetic patients and also recommendation for controlling diabetes during this pandemic situation. The article also discusses the case study of COVID-19 at various regions around the globe and the preventive actions taken by various countries to control the effect from the virus. The article presents several smart healthcare solutions for the diabetes patients to have glucose insulin control for the protection against COVID-19.
---
PDF链接：
https://arxiv.org/pdf/2008.11153